Introduction
The serine protease inhibitors (serpins) present in human plasma serve important functions as specific inhibitors of the coagulation, contact activation, fibrinolytic, and complement cascades ( 1) . Serpins share a common mechanism by present-ing an exposed loop as substrate for target proteases, and proteolytic attack results in the formation of very stable, essentially irreversible complexes. Remarkably, the reactive center loop of several serpins, notably antithrombin III, a2-antiplasmin, and Cl inhibitor, contains additional cleavage sites for neutrophil elastase (2) (3) (4) . It was proposed that the susceptibility of these serpins for catalytic inactivation serves a physiological purpose by allowing localized proteolytic activity at inflammatory sites (5) . In accord with this concept, stimulated neutrophils release oxygen radicals and metalloproteases (6) (7) (8) , which in concert inactivate a 1 -antitrypsin, thereby creating a microenvironment in which human neutrophil elastase (HNE)' is no longer inhibited. These events presumably contribute to tissue destruction in local inflammatory reactions and to dysregulation of plasma cascade systems in systemic inflammation, such as septic shock, in which massive neutrophil activation occurs.
Recombinant serpins derived from a 1 -antitrypsin are inherently insensitive to inactivation by HNE and have been tested for therapeutic use in the shock syndromes (9-1 1 ). However, the a 1 -antitrypsin background may impose restrictions on their specificity; for example, none of the described variants is an efficient inhibitor ofthe complement proteases Cl r and Cl s ( 1 1, 12) . Cl inhibitor is a plasma glycoprotein with an apparent relative molecular mass of 104,000 in SDS gels, but the actual relative molecular mass has been shown to be -76,000 ( 13) . Genetic defiency of Cl inhibitor, resulting from either quantitative or structural defects, is the cause for the disease hereditary angioedema ( 14, 15) . Because Cl inhibitor is the most effective inhibitor in vivo of the complement proteases C 1 r and C I s, and the contact activation proteases Factor XIIa and kallikrein (16) (17) (18) , all of which have been implicated to contribute to septic shock (9, 19, 20) , we decided to investigate whether its sensitivity for proteolytic inactivation by HNE could be reduced without loss of function.
Methods
Enzymes and reagents. Enzymes for recombinant DNA techniques were obtained as described previously, as were Cl inhibitor, C Is, fFactor XlIa, and kallikrein (all human) (reference 21 and references therein). Human plasmin was a kind gift of Dr. Colin Longstaff (National Institute for Biological Standards and Control, South Mimms, Hertfordshire, UK). Human neutrophil elastase was purchased from Elastin Products (Pacific, MO). Chromogenic substrates S-2314 and S-2302 were obtained from Kabi AB (Stockholm, Sweden). Heparin grade I ( 181 U/mg, molecular weight range 15,000-18,000), FMLP, cytochalasin B, phorbol myristate acetate (PMA), and 1, 10-phenanthroline were obtained from Sigma Immunochemicals (St. Louis, MO).
[35S] methionine (specific activity > 37 TBq/mmol) was purchased from the Radiochemical Centre (Amersham, UK).
Mutagenesis, expression andpurification ofrecombinant Cl inhibitor. A 300-bp EcoRI-SstI fragment from the COS-1 expression vector pC I inhibitor (22) was subcloned in Ml 3mp I 8-mp4 and used as template for mutagenesis according to published procedures (21, 23 ). Antisense primers coding for the desired mutations at P5 (440-Ile) and P3 (442-Val) were synthesized on DNA synthesizer (type 38 1A; Applied Biosystems, Warrington, UK). Because we wanted to preserve the inhibitory functions ofC I inhibitor, most substitutions were semiconservative in nature and maintained the medium-sized aliphatic side chain of the wild type P5(Ile) and P3(Val) residues. Mutations at P3 only were constructed with the following oligomers (mismatched bases are underlined): P3-Ala: 5'-GGTGCGGGCGGCAGAGATGG-3' P3-Gly: 5'-GGTGCGGGCTCCAGAGATGG-3' P3-Arg: 5'-GGGTGCGGGCTCTAGAGATGGCG-3' P3-Leu: 5'-GCGGGCCAGAGAGATGG-3' P3-Thr: 5'-GGGTGCGGGCGGTAGAGATGGCG-3' Mutagenesis at both P5 and P3 was performed with a degenerate oligomer coding for combinations ofconservative amino acid substitutions, with the following sequence:
12 clones coding for substitutions at P5 (440-Ile) and/or P3 (442-Val) were identified; 3A, 3G, 3R, 3L, 3T, 5L3A, 5L3L, 5L3V, 5V3A, 5V3L, 5A3A, and 5V (numbers refer to P5 or P3 positions in the reactive center ofC I inhibitor, amino acids are designated by standard one-letter code). The EcoRI-SstI fragment was reinserted in the expression vector and, after large scale plasmid preparation, double strand sequencing was performed to ensure that no other mutations had occurred. Transfection ofthe COS-1 cell line was performed as described (22) , and the serum-free conditioned medium was assayed for the presence of Cl inhibitor antigen by a RIA using a solid-phase monoclonal antibody ( 19). The amino acid changes did not affect detection in this assay (not shown). Expression levels varied between 1 and 3 ,ug/ ml. Recombinant Cl inhibitor (rCl inh) variants were purified by lectinaffinity chromatography on jacalin agarose (Pierce Chemical Co., Rockford, IL) (24), as described in detail previously (21 Fig. 1 demonstrates the ability of rC 1 inh-5L3A and -5V3A to form SDS-stable complexes with f-Factor XIIa, kallikrein, and plasmin. Plasmin was included in these experiments because inhibition of plasmin by Cl inhibitor has been demonstrated in vitro (28) . Incubation with plasmin yielded complexes of 160 kD and degradation products of 97 and 86 kD (lanes 4, 7, and 10), the latter two most likely resulting from cleavage at the reactive site and/or at the NH2 terminus of C 1 inhibitor, as has been described (28) . There was no increase in cleavage of the variants by plasmin. The other results shown in Fig. 1 agree well with those of the RIAs presented in Table I ; complex formation with f-Factor XIIa appeared unaffected Fig. 2 , the resistance ofrC 1 inh-5L3A against proteolytic inactivation by HNE is directly visualised. Although the degradation pattern characteristic of HNE (3) was also observed with rC 1 inh-5L3A (Fig. 2 A) , much higher HNE concentrations were required. The NH2-and COOH-terminal fragments cleaved off by HNE (3) are visible in the dye-front of the gel. Cls. It can be seen that both rC1 inh-wt and -5L3A formed complexes with C Is of 180 kD, and that after partial NH2-terminal cleavage by HNE, rC 1 inh-5L3A formed a complex of about 170 kD (Fig. 2 B, lane 9 ). Densitometric scanning ofthe gel shown in Fig. 2 Fig. 2 with 5V3A, and a more recently obtained 5A3A Cl inhibitor variant, which also displayed HNE resistance. The results obtained with these two latter variants looked very similar to those in Fig. 2, A and B. As the results of densitometric scans in Table II show, rC 1 inh-5V3A behaved almost identically to wild type, and rCl inh-5A3A behaved like 5L3A, with the difference that 5A3A appeared slightly less resistant to inactivation by HNE, and generated a somewhat more cleaved 94-kD Cl inhibitor upon incubation with C ls alone. These experiments show that rC1 inh-5L3A and -5A3A resisted inactivation and remained functional for a prolonged period in the presence of HNE. Additional experiments (not shown) established that the smallest fragment ofC I inhibitor capable ofcomplex formation is -50 kD, representing the serpin domain with the NH2-terminal part containing most of the carbohydrate sidechains (13) cleaved off.
It has been reported that cleavage of Cl inhibitor proceeds faster in the presence of intact, stimulated neutrophils in comparison with only the supernatant of activated cells (3). In addition, much attention has been given recently to the serpincleaving activity of metalloproteases, exerted in combination with reactive oxygen species released from triggered neutrophils (29, 30) . Neutrophil collagenase was shown to cleave several serpins, notably al-antitrypsin and Cl inhibitor, the latter being cleaved between P6 and P5 (31) . Therefore, we performed experiments to investigate the relative importance of serineproteases, metalloproteases, and the oxidative burst in cleavage of Cl inhibitor. Second, we tested whether the P5/P3 variants that resisted cleavage by purified HNE and the super- natant ofactivated neutrophils would retain this capacity in the presence of intact, stimulated cells. In Fig. 3 A, the decrease in Cl inhibitor activity upon stimulation of neutrophils by either PMA or FMLP is shown. It appeared that the decline in inhibitor activity, determined by titration against Cl s in a subsequent incubation, proceeded significantly faster after stimulation with FMLP than with PMA. The former is known (especially in the presence of cytochalasin B) to generate a fast degranulation concurrently with the oxidative burst (32) , and the latter yields a fast burst and a relatively slow degranulation (33). Next, neutrophils were stimulated in the presence of various inhibitors. Eglin C inhibits the serine proteases HNE, proteinase 3, and cathepsin G (34, 35), 1, 10-phenanthroline is an inhibitor of metalloproteases, and diphenyleneiodonium (DPI) was used as a specific inhibitor of the NADPH oxidase (36) . The results, shown in Fig. 3 A detailed evaluation with respect to complex stability and kinetic constants of all 12 rC1 inhibitor P5/P3 variants with the various target proteases is beyond the scope of the present article and will be reported elsewhere (Eldering, E., C. C. M. Huijbregts, Y. T. P. Lubbers, C. Longstaff, J. H. Nuijens, and C. E. Hack, manuscript submitted for publication). In agreement with the results presented here, kinetic analysis under pseudo-first order conditions generated association rate constants with C Is of purified rC 1 inh-P5 /P3 variants that varied between 1.3 X 104 M-1s-' for rCl inh-3R and 4.2 x 104 M-'s-' for wild type. Fig. 5 shows a representative example of an inhibition experiment with C ls and purified rC 1 inh-wt. The inset shows the linear relationship between I and the apparent rate constant kobs for rC 1 inh-wt and 5L3A. As described (21 ) , the overall inhibition mechanism conformed to a onestep reversible reaction. The observed koffvalue ofwild type Cl inhibitor is too low, however ( 1-2 X 10-6 s-' ) to be physiologically relevant (21 ) and no significant changes were found for the P5/P3 variants (Eldering, E., C. C. M. Huijbregts, Y. T. P. Lubbers, C. Longstaff, J. H. Nuijens, and C. E. Hack, manuscript submitted for publication). The association rate of purified Cl inhibitor with Cl s, which is relatively low compared to other serpin-protease interactions ( 1 ), appears to be augmented upon addition of heparin (38, 39) , or when measured with C Is incorporated in the complete Cl complex (40) . The reaction rate ofthe P5 /P3 variants was stimulated in the presence of heparin to a similar extent as that ofplasma and recombinant C inhibitor wild type, as demonstrated in Fig. 6 for rC1 inh-5L3A. Comparable sets of inhibition progress curves were obtained for rC 1 inh-wt, -5L3A, -5L3L and -5V3A. The increase in k0n for Cls in the presence of 10 U/ml heparin was similar, generating an average stimulation factor of 8.4±0.6. These results indicated that the structural determinants that mediate the interaction with heparin are unperturbed in the P5 /P3 variants.
Association rates with f-Factor XIIa were obtained as described (21, 27 Approximately a fivefold reduction in k.. was found for 5L3A and 5A3A, and 5V3A appeared to react almost ninefold slower than wild type. Table III summarizes the results of the kinetic studies for rC1 inh-wt, the HNE-resistant 5L3A, 5L3L, and 5A3A variants, and the 5V3A variant. The values of the rate constants obtained for rC 1 inh-wt with C Is, f-Factor XIIa and kallikrein corresponded well with those published for purified plasma Cl inhibitor ( 17, 27, 38, 41 
Discussion
Several studies have demonstrated the therapeutic potential of recombinant serpins derived from a 1 -antitrypsin in inflammatory conditions (9, 10) . However, these and other ( 1 1, 42) reports have also attenuated earlier expectations (43, 44) that the specificity of serpins could be predictably modified by alterations in the reactive site loop, based on the known substrate specificity of target proteases and on comparisons of serpin loop sequences. It is now generally agreed that residues outside the reactive site loop are also critical in defining specificity; e.g., as has been demonstrated recently for plasminogen activator inhibitor-1 (45) . Furthermore, it is becoming increasingly clear that the reactive site loop of serpins is a highly specialized structure (46, 47) that probably cannot be directly compared to small substrates. The results presented here demonstrate the feasibility of an alternative strategy that maintains the inherent specificity of serpins to construct variants that are resistant to catalytic inactivation by nontarget proteases. Conservative substitutions at both HNE cleavage sites in the reactive centre loop ofCl inhibitor can apparently reduce the proteolytic inactivation by HNE about 16-fold, while the specific interaction with various target proteases seems moderately affected. Since our efforts were aimed at obtaining HNE resistance, as well as at preserving inhibitory function, the amino acid changes were predominantly semiconservative. Of 12 variants constructed, rC1 inh-5L3A, -5L3L and -5A3A displayed significant resistance to purified HNE, as well as to stimulated neutrophils. Complete HNE resistance was not obtained with the substitutions used, which is perhaps not surprising considering the general preference of HNE for P1 residues with a medium-sized aliphatic side chain (48) . There was a good correlation, however, between the order of P1 residues preferred by HNE in small peptide substrates and chloromethylketone inhibitors (Ile = Val > Leu > Ala) (48) (49) (50) (51) , and the substitutions conferring HNE resistance in C I inhibitor (Leu or Ala for Ile or Val). In addition, our results were also in agreement with computer modeling that has predicted that P 1-Ile would be a better substrate for HNE than Pl-Leu (48) . Functional capacity of the variants could be demonstrated by the formation of stable complexes with C Is, fl-Factor XIIa, kallikrein and plasmin, both with radioimmunoassays and on SDS gels. Kinetic analyses indicated that the association rate constant with Cls for the HNE-resistant variants is reduced twofold at most, and seems unaffected with :-Factor XIIa. The effect of the substitutions on the association rate constant with kallikrein ranged from a quite significant ninefold reduction in the case of 5V3A to an unchanged association rate for 5L3L. It appears that especially the P3 amino acid is more critical in the interaction with kallikrein compared with f-Factor XIIa and C Is. Collectively, the results from kinetic analyses showed that rC 1 inh-5L3L has unperturbed functional characteristics, while the various inactivation experiments demonstrated that 5L3A has the highest resistance to HNE-mediated cleavage. The RIAs using solid-phase proteases provided a quick and sensitive screen to detect (residual) binding capacity. Some discrepancies between the RIAs and kinetic experiments were observed; e.g., we found that in the f-Factor XIIa RIA, 5L3A binds for -46% compared to wild type, but kinetic analysis indicated similar association rate constants. These differences may result from the fact that Sepharose-coupled proteases appear to react slower with C 1 inhibitor, and also with chromogenic substrates (unpublished observations). In our experience, only the absence of binding, or a drastic reduction, in the RIAs indicates a complete or significant loss of function (i.e., leading to a > 10-fold reduction in k0n, see also reference 21 ).
An important observation with these HNE-resistant variants was that the amino acid changes did not result in significantly increased inhibitor turnover by target proteases. This was evident from SDS-PAGE analysis (Figs. 1 and 2 B, Table II) , and also from studies that monitored the possible appearance of cleaved rC1 inhibitor upon interaction with target proteases under nondenaturing conditions (Eldering, E., C. C. M. Huijbregts, Y. T. P. Lubbers, C. Longstaff, J. H. Nuijens, and C. E. Hack, manuscript submitted for publication). In contrast, certain recombinant serpins derived from a 1 -antitrypsin have been shown to be cleaved considerably by plasmin in vitro ( 12) , and are reported to circulate in the cleaved form in septic shock (52) .
Since maximally only two residues in the reactive centre loop were exchanged, perturbations of the overall Cl inhibitor tertiary structure can be presumed to be nonexistent or minimal in the variants described here. This may be advantagous in a physiological setting, where it can be expected that any specific interaction with potential third components is maintained. Although Cl inhibitor is not generally viewed as a heparin-dependent serpin, it is known that its activity against C I s is stimulated in the presence of this glycosaminoglycan (38, 39) . Inhibition experiments in the presence of heparin indeed demonstrated that the activity of the P5 / P3 variants is stimulated identical to wild type Cl inhibitor, indicating that the substitutions did not interfere with the determinants that mediate this specific interaction.
Apart from the well-established capacity ofHNE to catalytically cleave serpins such as antithrombin III, a2-antiplasmin, and Cl inhibitor (2-4), various articles in recent years have described that metalloproteases, in combination with reactive oxygen species, can also cleave serpins, in particular a l-antitrypsin, near the reactive center (29, 30) . This "serpinase" (53) activity of metalloproteases is, however, relatively low (i.e., 24-h incubations are needed to generate significant serpin cleavage in most reports), and is measured in the supernatant of activated neutrophils after addition of the serine protease 
